Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subjective vs Objective Psoriasis Severity Assessment Tools After Cyclosporine A or Methotrexate
NCT02655705Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Aug 2014
- Primary completion
- Mar 2016
- Modality
- Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in psoriasis comparing Cyclosporine A with Methotrexate (2 arms). Primary endpoints: Psoriasis Area and Severity Index at 16 weeks and Objective Psoriasis Area and Severity Index at 16 weeks. Started Aug 2014; status: completed.
02
Drugs
cyclosporinemethotrexate
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT02655705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02655705.